https://orcid.org/0000-0002-2621-8388
References
- Schwartzbaum JA, Fisher JL, Aldape KD, et al. Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2006;2:494–503.
- Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97–109.
- Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 2016;131:803–20.
- Stupp R, Tonn JC, Brada M, et al. High-grade malignant glioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21:v190–3.
- Stupp R, Reni M, Gatta G, et al. Anaplastic astrocytoma in adults. Crit Rev Oncol Hematol 2007;63:72–80.
- Ostrom QT, Gittleman H, Liao P, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2012–2016. Neuro Oncol 2014;16:iv1–63.
- Danks RA, Chopra G, Gonzales MF, et al. Aberrant p53 expression does not correlate with the prognosis in anaplastic astrocytoma. Neurosurgery 1995;37:246–54.
- Grimm SA, Chamberlain MC. CNS oncology anaplastic astrocytoma. CNS Oncol 2016;5:145–57.
- Al-Tamimi YZ, Palin MS, Patankar T, et al. Low-grade glioma with foci of early transformation does not necessarily require adjuvant therapy after radical surgical resection. World Neurosurg 2018;110:e346–54.
- Coons SW, Pearl DK. Mitosis identification in diffuse gliomas: implications for tumor grading. Cancer 1998;82:1550–5.
- Jiang H, Ren X, Zhang W, et al. A new prognostic scoring scale for patients with primary WHO grade III gliomas based on molecular predictors. J Neurooncol 2013;111:367–75.
- Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiology 1999;10:37–48.
- Textor J, van der Zander B, Gilthorpe MS, Liskiewicz M, Ellison GT. Robust causal inference using directed acyclic graphs: the R package “dagitty”. Int J Epidemiol 2016;45:1887–94.
- Westreich D, Greenland S. The table 2 fallacy: presenting and interpreting confounder and modifier coefficients. Am J Epidemiol 2013;177:292–8.
- Shirahata M, Ono T, Stichel D, et al. Novel, improved grading system(s) for IDH-mutant astrocytic gliomas. Acta Neuropathol 2018;136:153–14.
- Pekmezci M, Rice T, Molinaro AM, et al. Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT. Acta Neuropathol 2017;133:1001–16.
- Lopez XM, Debeir O, Maris C, et al. Clustering methods applied in the detection of Ki67 hot-spots in whole tumor slide images: an efficient way to characterize heterogeneous tissue-based biomarkers. Cytometry A 2012;81:765–75.
- Goacher E, Randell R, Williams B, et al. The diagnostic concordance of whole slide imaging and light microscopy: a systematic review. Arch Pathol Lab Med 2017;141:151–61.
- Menze BH, Jakab A, Bauer S, et al. The multimodal brain tumor image segmentation benchmark (BRATS). IEEE Trans Med Imaging 2015;34:1993–2024.
- van der Hoorn A, Yan JL, Larkin TJ, et al. Validation of a semi-automatic co-registration of MRI scans in patients with brain tumors during treatment follow-up. NMR Biomed 2016;29:882–9.